Correlation Between Day One and AbbVie

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Day One and AbbVie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and AbbVie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and AbbVie Inc, you can compare the effects of market volatilities on Day One and AbbVie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of AbbVie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and AbbVie.

Diversification Opportunities for Day One and AbbVie

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Day and AbbVie is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and AbbVie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AbbVie Inc and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with AbbVie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AbbVie Inc has no effect on the direction of Day One i.e., Day One and AbbVie go up and down completely randomly.

Pair Corralation between Day One and AbbVie

Given the investment horizon of 90 days Day One is expected to generate 1.42 times less return on investment than AbbVie. In addition to that, Day One is 2.35 times more volatile than AbbVie Inc. It trades about 0.02 of its total potential returns per unit of risk. AbbVie Inc is currently generating about 0.07 per unit of volatility. If you would invest  13,342  in AbbVie Inc on September 14, 2024 and sell it today you would earn a total of  3,992  from holding AbbVie Inc or generate 29.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Day One Biopharmaceuticals  vs.  AbbVie Inc

 Performance 
       Timeline  
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
AbbVie Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AbbVie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's fundamental drivers remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Day One and AbbVie Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Day One and AbbVie

The main advantage of trading using opposite Day One and AbbVie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, AbbVie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will offset losses from the drop in AbbVie's long position.
The idea behind Day One Biopharmaceuticals and AbbVie Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope